心玮医疗：国内创新型神经介入医疗器械公司

Gelonghui
2021.08.10 05:30

拥有国内首个全套取栓器械

今天为大家带来【心玮医疗】的新股评级。本评级主要围绕基本盘、实操盘两大维度，针对目标公司各项核心指标进行打分评级，满分为 10 分，各指标单独评分，按 “(权重占比 * 分数) 之和” 计算，最终结果按照四舍五入得到。格隆汇新股研究根据已公开数据及独家的内部评级体系，给予【心玮医疗】的新股综合评估分数为【7.6】(满分为 10 分），如下图：

Source: Gelonghui The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.